PeDiAC: Pediatric Videolaryngoscopic Intubation and Difficult Airway Classification

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Completed
CT.gov ID
NCT04844723
Collaborator
(none)
809
1
15.7
51.5

Study Details

Study Description

Brief Summary

The study's primary aim is to develop and validate a multivariable diagnostic model for the prediction of difficult videolaryngoscopy (the 'PeDiAC classification') in children undergoing general anesthesia with tracheal intubation. The secondary aim is to compare the diagnostic performance of the PeDiAC-classification with the Cormack-Lehane classification.

Detailed Description

Difficult tracheal intubation is one of the major reasons for anesthesia-related adverse events. Videolaryngoscopy has become an important part of the anesthesiology standard of care for difficult airway management in the past decades. This is especially relevant in children, as their airway anatomy differs greatly from adults because they are likely incapable of tolerating brief apneic episodes. Still, medical preconditions and procedural and technical factors related to difficult videolaryngoscopy have not been broadly investigated and not fully been understood.

The primary aim of the PeDiAC study is to develop and validate a multivariable diagnostic model for the classification of difficult videolaryngoscopy (the 'PeDiAC classification') in children undergoing general anesthesia with tracheal intubation. Study planning and conduction are in accordance with the TRIPOD 'Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis' statement. The secondary aim is to compare the diagnostic performance of the PeDiAC-classification with the Cormack-Lehane classification, which is the current clinical standard for assessing intubation via direct laryngoscopy. We conduct a prospective observational study that will include approximately 800 pediatric patients within one year scheduling for tracheal intubation. Patients with age below 18 years will be considered to be eligible for inclusion. Procedural and surgical data, as well as medical preconditions, will be assessed systematically. After tracheal intubation, performed by the responsible anesthetist, the intubation process will be rated by the responsible anesthetist and an additional independent observer, and detailed information regarding procedural and technical factors related to videolaryngoscopy will be documented. All sampled independent variables will be considered to be potential candidate predictors for the multivariable regression model.

Study Design

Study Type:
Observational
Actual Enrollment :
809 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Pediatric Videolaryngoscopic Intubation and Difficult Airway Classification
Actual Study Start Date :
Apr 12, 2021
Actual Primary Completion Date :
Aug 3, 2022
Actual Study Completion Date :
Aug 3, 2022

Outcome Measures

Primary Outcome Measures

  1. Difficult videolaryngoscopic intubation [1 hour]

    Rating by the responsible anesthetist

Secondary Outcome Measures

  1. First pass success rate [1 hour]

    Percentage of successful intubations with one attempt

  2. Overall success rate with the first-choice technique [1 hour]

    Percentage of successful intubations without transition to another technique

  3. Number of attempts [1 hour]

    Total number of laryngoscopy and intubation attempts until airway established

  4. Change of airway technique [1 hour]

    Transition to a different technique, i.e. flexible bronchoscopy, surgical airway, supraglottic airway as clinically assessed (Yes/No)

  5. Best glottic view [1 hour]

    Best view on the larynx obtained during laryngoscopy assessed by Cormack/Lehane classification (grade I to IV)

  6. Time to best view [1 hour]

    Time until optimal view conditions during laryngoscopy

  7. Intubation time [1 hour]

    Time until successful tracheal intubation

  8. Intubation difficulty, ease of intubation and quality of visualisation [1 hour]

    Subjective ratings on visual analogue scales (0 to 100 with 0 being the best)

  9. Post-intubation recommendation for an intubation method [1 hour]

    Requirement of recommendation for further intubations of the responsible anesthetist

  10. Post-intubation recommendation for an anesthesia alert cart [1 hour]

    Recommendation of the responsible anesthetist (yes/no)

  11. Post-intubation diagnosis of 'difficult intubation' [1 hour]

    Rating of the responsible anesthetist

  12. Airway-related adverse events [1 hour]

    Laryngospasm, bronchospasm, larynx trauma, airway trauma, soft tissue trauma, oral bleeding, edema, dental damage, corticosteroid application, accidental esophageal intubation, aspiration, hypotension or hypoxia

  13. Difficult bag-mask ventilation [1 hour]

    As clinically assessed (yes/no) by the responsible anesthetist

  14. Lowest oxygen saturation [1 hour]

    Measured with pulsoxymetry during anesthesia

  15. Hypercapnia [1 hour]

    Measured endtidal carbon dioxide after successful intubation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pediatric patients undergoing general anesthesia with tracheal intubation in the study center.

  • Informed consent obtained

  • Age < 18 years

Exclusion Criteria:
  • Anesthetist prefers conventional laryngoscopy

  • Indication for intubation via a bronchoscope or awake intubation

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Medical Center Hamburg-Eppendorf Hamburg Germany 20246

Sponsors and Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

Investigators

  • Study Director: Martin Petzoldt, MD, Universitätsklinikum Hamburg-Eppendorf
  • Study Chair: Thorsten W Dohrmann, MD, Universitätsklinikum Hamburg-Eppendorf
  • Study Chair: Christian Zöllner, MD, Universitätsklinikum Hamburg-Eppendorf

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier:
NCT04844723
Other Study ID Numbers:
  • 2021-10380-BO-ff
First Posted:
Apr 14, 2021
Last Update Posted:
Aug 23, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Universitätsklinikum Hamburg-Eppendorf

Study Results

No Results Posted as of Aug 23, 2022